The UGMC Board

Dr. Anarfi Asamoa-Baah was the Deputy Director of the World Health Organization for a period of Ten years, from 2007-2017. Before he was appointed Deputy Director General, he held various senior positions at the World Health Organization (“WHO”), ranging from Senior Policy Adviser to the Director General, Executive Director, Governing Bodies, Partnerships and Country Support Executive Director, Health Technologies and Pharmaceuticals, Assistant Director General, Communicable Diseases and Assistant Director General, HIV, TB, Malaria Clusters.

 

Dr. Asamoa-Baah graduated from the University of Ghana Medical School and had his postgraduate training in Community Health, Health Planning, Health Economics and Health Policy in the United Kingdom, United States of America, and Denmark. He has served on the boards of the Global Fund for TB, HIV & Malaria, Global Alliance for Vaccines, and Immunization (GAVI), The Partnership for Maternal, Newborn and Child Health, the Stop TB Partnership, and the Roll Back Malaria Partnership. 

 

Some of the key achievements during his time at WHO include the establishment of the 2005 International Health Regulations, Global Visibility for Neglected Tropical Diseases, the revitalization of Primary Healthcare, the establishment of the Pre-qualification programme as part of the WHO Essential Medicines Programme and the development of the first Global Strategy for Traditional Medicine.  He is now based in Ghana, where he is a Presidential Advisor on Science, Technology and Innovation and was recently appointed as the Presidential Advisor for COVID-19.